Vexim received approval from the Therapeutic Goods Administration to market SpineJack® and the Masterflow™ cement delivery system in Australia. Product is slated for initial export within 2016.
Other activity in Australia during 2016 includes:
- Regulatory clearance for Centinel Spine’s STALIF L and expansion of MIDLINE II-TI sales there
- Safe Orthopaedics entered a distribution agreement covering Australia and New Zealand
- Tyber Medical entered the region
Sources: Vexim; ORTHOWORLD Inc.
Vexim received approval from the Therapeutic Goods Administration to market SpineJack® and the Masterflow™ cement delivery system in Australia. Product is slated for initial export within 2016.
Other activity in Australia during 2016 includes:
Regulatory clearance for Centinel Spine's STALIF L and expansion of MIDLINE II-TI sales there
...
Vexim received approval from the Therapeutic Goods Administration to market SpineJack® and the Masterflow™ cement delivery system in Australia. Product is slated for initial export within 2016.
Other activity in Australia during 2016 includes:
- Regulatory clearance for Centinel Spine’s STALIF L and expansion of MIDLINE II-TI sales there
- Safe Orthopaedics entered a distribution agreement covering Australia and New Zealand
- Tyber Medical entered the region
Sources: Vexim; ORTHOWORLD Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





